As illustrated in Fig. 1A, we found that PART1 was overexpressed in kidney chromophobe (KICH), ovarian serous cystadenocarcinoma (OV), thymoma (THYM), and uterine corpus endometrial carcinoma (UCEC). This evidence concerns the gene PART1 and thymoma.